Julie Stupke
Psychiatry · Raleigh, NCNPI 1598338238
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 324 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 24.0% of the total. Reporting peaked in 2023 at $2,431 and has fallen 93.1% since, to $169 in 2025. Among psychiatry clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 324 payments — averaging $18.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- AbbVie$1K
- Teva Pharmaceuticals USA, Inc.$464
- Johnson & Johnson$358
- Lundbeck LLC$352
- Supernus Pharmaceuticals, Inc.$342
- plus $2K from 18 others
What the payments were for
- Food & beverage$6,083100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 80 | $1,465 |
| AbbVie | 65 | $1,042 |
| Teva Pharmaceuticals USA, Inc. | 19 | $464 |
| Johnson & Johnson | 12 | $358 |
| Lundbeck LLC | 18 | $352 |
| Supernus Pharmaceuticals, Inc. | 26 | $342 |
| Alkermes, Inc. | 9 | $339 |
| Otsuka America Pharmaceutical, Inc. | 19 | $325 |
| Bausch Health US, LLC | 10 | $184 |
| Axsome Therapeutics, Inc. | 4 | $182 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $162 |
| Neos Therapeutics, LP | 9 | $152 |
| Sunovion Pharmaceuticals Inc. | 8 | $127 |
| Corium, LLC | 6 | $127 |
| Vanda Pharmaceuticals Inc. | 7 | $121 |
| Noven Therapeutics, LLC | 6 | $104 |
| Tris Pharma Inc | 2 | $38 |
| Indivior Inc. | 2 | $37 |
| Neurocrine Biosciences, Inc. | 2 | $35 |
| Almatica Pharma LLC | 2 | $35 |
| Merck | 2 | $34 |
| Eisai Inc. | 2 | $30 |
| Idorsia Pharmaceuticals US Inc | 2 | $26 |
| Adlon Therapeutics L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,095 in reported general payments places this provider in the 90th percentile of 1,108 psychiatry providers in North Carolina.
Other psychiatry in Raleigh
- Robert MilletRaleigh$476K
- Richard WeislerRaleigh$108K
- Ashwin PatkarRaleigh$103K
- Mona GuptaRaleigh$88K
- Kellie TolinRaleigh$31K
- Celso LobaoRaleigh$28K
- Elizabeth CoxRaleigh$24K
- Myleme HarrisonRaleigh$13K
- Craig ChepkeHuntersville$4.1M
- Mark ReynoldsDurham$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.